|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)
Young & Rubicam Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
987425105
- --------------------------------------------------------------------------------
(CUSIP Number)
Mark T. McEnroe, c/o Young & Rubicam Inc.,
285 Madison Avenue, New York, New York 10017, 212-210-3427
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
May 28, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7(b) for
other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that Section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
1. NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Michael J. Dolan
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [x]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
00
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
0
NUMBER -----------------------------------------------------
OF 8. SHARED VOTING POWER
SHARES
BENEFICIALLY 1,236,299
OWNED BY -----------------------------------------------------
EACH 9. SOLE DISPOSITIVE POWER
REPORTING
PERSON 332,699
WITH -----------------------------------------------------
10. SHARED DISPOSITIVE POWER
45,000
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,613,998
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[x]
See Item 6 below
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.3%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE>
1. NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Stehpanie W. Abramson
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [x]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
00
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
0
NUMBER -----------------------------------------------------
OF 8. SHARED VOTING POWER
SHARES
BENEFICIALLY 1,236,299
OWNED BY -----------------------------------------------------
EACH 9. SOLE DISPOSITIVE POWER
REPORTING
PERSON 265,765
WITH -----------------------------------------------------
10. SHARED DISPOSITIVE POWER
142,830
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,644,894
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[x]
See Item 6 below
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.3%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE>
1. NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mark T. McEnroe
- --------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [x]
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. SOURCE OF FUNDS
00
- --------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- --------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
7. SOLE VOTING POWER
0
NUMBER -----------------------------------------------------
OF 8. SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -----------------------------------------------------
EACH 9. SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH -----------------------------------------------------
10. SHARED DISPOSITIVE POWER
11,025
- --------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,025
- --------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
[x]
See Item 6 below
- --------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 0.1%
- --------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
IN
- --------------------------------------------------------------------------------
<PAGE>
This Amendment No. 2 (this "Amendment") amends and supplements the Schedule
13D filed on May 7, 1999, as amended by Amendment No. 1 ("Amendment No. 1")
filed on May 25, 1999 (as so amended, the "Original Schedule 13D"), by Michael
J. Dolan, Stephanie W. Abramson and Mark T. McEnroe with respect to the common
stock, par value $0.01 per share ("Common Stock"), of Young & Rubicam Inc., a
Delaware corporation (the "Company"). All capitalized terms used in this
Amendment and not otherwise defined herein have the meanings ascribed to them in
the Original Schedule 13D.
Item 4. Purpose of Transaction.
Item 4 of the Original Schedule 13D is hereby amended by inserting the
following paragraph immediately prior to the final paragraph thereof.
On May 28, 1999 (the "Closing Date"), the Y&R Selling Stockholders listed
on Schedule 1 hereto and the KBM Selling Stockholders listed on Schedule 2
hereto, together with certain other stockholders of the Company, closed the sale
of Common Stock pursuant to the Underwriting Agreement. Pursuant to the
Underwriting Agreement, the Y&R Selling Stockholders sold to the Underwriters,
acting through the Representatives, 6,858,528 shares of Common Stock (including
2,011,960 shares of Common Stock issued upon exercise of options held by the Y&R
Selling Stockholders), and the KBM Selling Stockholders sold to the
Underwriters, acting through the Representatives, 641,472 shares of Common Stock
for resale pursuant to the Company's Registration Statement on Form S-1 and the
Final Prospectus, at a price of $37.2500 per share, less an underwriting
discount of $1.2665 per share, resulting in net proceeds to the Y&R Selling
Stockholders and KBM Selling Stockholders of $35.9835 per share of Common Stock.
In addition, other stockholders of the company named in the Underwriting
Agreement and the Final Prospectus sold 7,500,000 shares of Common Stock to the
Underwriters, acting through the Representatives. In addition, in accordance
with the Underwriting Agreement, the U.S. Underwriters, acting through the U.S.
Representatives, exercised their option to purchase an additional 949,660 shares
of Common Stock (including 279,292 shares of Common Stock issued upon exercise
of options) in connection with the Secondary Public Offering, solely to cover
over-allotments in connection with the sale of shares of Common Stock, from
those Y&R Selling Stockholders listed on Schedule 3 hereto in the respective
amounts listed on such Schedule 3, and an additional 1,300,340 shares of Common
Stock from certain other stockholders, which purchase closed on the Closing
Date.
Item 5. Interest in Securities of the Issuer.
Item 5 of the Original Schedule 13D is hereby amended to read in its
entirety as follows:
(a) At the date hereof, Michael J. Dolan beneficially owns 1,613,998 shares
of Common Stock, constituting approximately 2.3% of the shares outstanding
(including 45,000 shares of Common Stock held in a deferral trust). At the date
hereof, Stephanie W. Abramson beneficially owns 1,644,894 shares of Common
Stock, constituting approximately 2.3% of the shares outstanding (including
142,830 shares of Common Stock held in a deferral trust). At the date hereof,
Mark T. McEnroe beneficially owns 11,025 outstanding shares of Common Stock held
in a deferral trust, constituting less than 0.1% of the shares outstanding. The
number of shares of Common Stock beneficially owned by each Reporting Person and
the percentage of outstanding shares represented thereby have been computed in
accordance with Rule 13d-3 under the Exchange Act.
(b) At the date hereof, Michael J. Dolan has the sole power to dispose of
332,699 shares of Common Stock, which includes 104,340 shares of Common Stock
which are issuable pursuant to currently exercisable options, held in an
individual capacity; and Stephanie W. Abramson has the sole power to dispose of
265,765 shares of Common Stock, which includes 26,085 shares of Common Stock
which are issuable pursuant to currently exercisable options, held in an
individual capacity.
As the holder of a voting proxy under the KBM Voting Agreements, each of
Stephanie W. Abramson and Michael J. Dolan share the power to dispose of
1,236,299 shares of Common Stock with Peter A. Georgescu, Thomas D. Bell, Jr.
and Edward H. Vick. The business address for each of Peter A. Georgescu, Thomas
D. Bell, Jr. and Edward H. Vick is c/o Young & Rubicam Inc., 285 Madison Avenue,
New York, New York 10017. Peter A. Georgescu is the Chief Executive Officer and
Chairman of the Board of Directors of the Company. Thomas D. Bell, Jr. is
Executive Vice President of the Company, Chairman and Chief Executive Officer of
Young & Rubicam Advertising and a Director of the Company. Edward H. Vick is the
Chief Operating Officer and a Director of the Company. During the last five
years, none of Messrs. Georgescu, Bell or Vick has been convicted in any
criminal proceeding (excluding traffic violations or similar misdemeanors) or
been a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, prohibiting or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws. Each of Messrs. Georgescu, Bell and Vick is
a United States citizen.
(c) Except as described herein, the Reporting Persons have effected no
transactions in shares of Common Stock since the filing of Amendment No.1.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: June 2, 1999
By: /s/ Mark T. McEnroe,
Attorney-in-Fact on behalf of
Michael J. Dolan
---------------------------------
Name: Mark T. McEnroe
Title: Attorney-in-Fact
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: June 2, 1999
By: /s/ Mark T. McEnroe,
Attorney-in-Fact on behalf of
Stephanie W. Abramson
---------------------------------
Name: Mark T. McEnroe
Title: Attorney-in-Fact
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: June 2, 1999
By: /s/ Mark T. McEnroe
----------------------
Name: Mark T. McEnroe
Title: Senior Vice President,
Young & Rubicam Inc.
<PAGE>
Schedule 1
Y&R Selling Stockholders
Maximum Number of
Shares of Common Stock
(including shares of
Common Stock issuable
upon the exercise of
Name of Y&R Selling Stockholder options)
------------------------------- --------
Stephanie Abramson 45,400
Stuart Agres 40,000
Stephen S. Aiello 20,672
Stig Albinus 10,000
Jean-Marc Bara 35,588
Bernard Barnett 1,050
Stephen Baum 3,120
Kimberly Bealle 20,000
Martin Beck 33,915
Urs Beer 25,000
Jed Beitler 11,225
Theodore A. Bell 60,000
Thomas D. Bell, Jr. 130,891
Tom Benelli 7,000
Thomas Blach 19,050
June Blocklin 10,225
Rene Boender 24,312
Bonnie Bohne 30,000
Etienne Boisrond 33,750
William Borrelle 1,841
Tiemen Bosma 40,000
Heinz-Georg Brands 22,712
Craig Branigan 46,446
Howard Breen 3,090
Jane Brite 99,810
T. J. Broadbent 15,500
David Butter 24,465
Ignacio Cabezon 10,720
Patricia Cafferata 16,000
Roger Chiocchi 14,191
Ira Chynsky 13,750
Michael Claes 7,500
Neil Clark 23,481
Don Cogman 61,601
Thomas Coleman 2,300
Janet Coombs 16,428
David Coronna 6,000
Jose Maria Costa 12,000
Massimo Costa 11,110
Charles Courtier 10,000
Michael Cozens 20,000
Dominique Damato 15,000
Donald H. Davis 19,080
Ferdinand de Bakker 60,000
Pierre de Roualle 25,000
Jerome Dean 18,000
Joseph E. Dedeo 134,172
Lawrence Deutsch 19,660
Shelley Diamond 13,314
Michael J. Dolan 41,926
Terry Dukes 6,150
Daryl Elliott 20,885
Daisy Exposito 26,953
Michael Faems 20,440
Charles P. Farley 2,100
Peter Farnell-Watson 14,494
John Fenton 6,500
Ian Ferguson Brown 2,250
Patrick Ford 6,055
Richard Ford 7,500
Clark J. Frankel 30,000
Volker Franz 16,385
Eric Fredericks 80,000
John Frew 6,030
Enrico Gervasi 12,033
Christopher Grabenstein 10,188
William Green 10,000
David E. Greene 5,000
Victor Gutierrez 27,145
Cynthia Hampton 10,000
Tom Hansen 2,000
Peter Harleman 16,000
Fred Hawrysh 5,000
Jan Hedquist 36,522
Per Heggenes 17,451
Stefan Himpe 3,000
Toby Hoare 55,000
Barry Hoffman 6,800
Charles Hollenkamp 3,000
James W. Hood 45,000
Penny Hooper 14,000
Roseanne Horn 12,675
Peter Horovitz 32,828
Richard Hosp 30,000
Eric Garrison Hoyt 7,670
Brian Hubbard 5,000
Jeff Hunt 17,014
Gigliola Ibba 21,000
Robert Igiel 52,170
Barbara Jack 178,560
Paal Marius Jebsen 11,085
William Johnston 19,185
James Kaplove 4,000
Mary Ellen Kenny 14,796
Kevin King 25,000
Edna Kissmann 21,500
Jackie Koh 27,535
Christopher Komisarjevsky 22,557
Satish Korde 96,727
Philippe Krakowsky 7,375
Ingo Krauss 162,000
Kurt Krauss 3,120
Stephanie Kugelman 57,011
Mitchell Kurz 356,000
Jay Kushner 11,994
Marta La Rock 15,000
Jean-Paul Lafaye 64,400
Timothy Laing 25,000
Robert Lallamant 19,566
Kevin Lavan 9,000
Mark Levine 15,219
Marco Lombardi 16,680
Bennett R. Machtiger 6,450
Duncan Mackinnon 7,000
John F. Maltese 13,575
Helmut Matthies 174,503
Martin Maurice 16,000
Robert M. McDuffey 10,506
John P. McGarry, Jr. 309,706
Austin McGhie 22,875
David McLean 31,853
Gordon McLean 11,955
Bert Meerstadt 14,440
William C. Melzer 73,300
Diane Meskill-Spencer 27,195
Craig Middleton 34,700
David Minear 40,000
Dominique Missoffe 15,474
Fernan Montero 158,000
Fred Moolhuijsen 15,000
Frans Mootz 26,622
John Morris 11,519
Janice Muniz 17,400
Bruce S. Nelson 28,250
Charles G. Newton, Jr. 3,600
Lori Nicholson 10,000
Lars Nordstrom 13,050
Laurie Null 10,850
Hans Ohman 13,050
Steve Oroho 59,010
Stewart Owen 33,054
Santiago Alonso Paniagua 38,715
Manuel Perez 40,704
Diane Perlmutter 8,035
Graham Phillips 40,000
Dan Plouffe 3,300
Tim Pollak 264,000
Michael Porter 2,500
William A. Power 42,000
Tom Pratt 6,385
Joerg Puphal 9,745
John E. Putnam 9,172
Matthias Quadflieg 1,484
Serge Rancourt 121,895
Sheila Raviv 20,000
Courtney Reeser 10,017
Ken Rietz 31,000
Jorg Rindlisbacher 19,500
Jorge Rodriguez 1,755
Robert Rosiek 2,170
John J. Ross 10,000
Maggie Ross 4,000
James Rossman 38,580
Seith Rothstein 33,915
Alain Rousset 55,352
Amy Rubenstein 14,736
Nicholas Rudd 39,132
Cas Saeys 27,465
Michael Samet 77,136
John Sanders 112,435
Chris Savage 52,000
Matthew Schetlick 8,185
Angelika Schug 3,400
Gertrude Schutz 11,217
Tom Schwartz 3,500
James Scielzo 23,052
Steve Seyferth 17,300
Keith Sharp 14,194
Jessie Shaw 10,000
Alan Sheldon 116,310
Thomas Shortlidge 44,000
Richard Sinreich 7,695
Robert Sive 13,236
Barbara Smith 10,000
Sylvia Soler 5,000
Linda Srere 50,000
Christoph Stadeler 85,705
Stanley Stefanski 160,642
Peter Steigrad 8,000
Debra Stern-Marrone 10,000
Peter Stringham 7,672
John Swan 28,000
Jane Talcott 5,217
Charlee Taylor-Hines 7,500
Lars Thalen 16,000
Clay Timon 85,088
Alan Vandermolen 33,390
John Vanderzee 39,132
Edward Vick 130,567
Marvin Waldman 25,305
Paula Waters 10,000
Charles Webre 55,656
Gus Weill 13,560
Robert Wells 12,500
Anders Wester 22,965
Bruno Widmer 40,000
James Williams 16,000
Allan Winneker 44,487
Bob Wyatt 2,500
Kenneth Yagoda 13,116
Joanne Zaiac 27,629
Michael Zeigler 2,900
TOTAL 6,858,528
<PAGE>
Schedule 2
KBM Stockholders
<TABLE>
<CAPTION>
Shares of Common Stock Being Sold Additional Shares of Common Stock
Name of KBM Stockholder in the Secondary Public Offering Subject to KBM Voting Agreement
----------------------- -------------------------------- -------------------------------
<S> <C> <C>
207 Ventures, LLC 14,652 0
Wand Affiliates Fund L.P. 567 0
Wand Equity Portfolio II, L.P. 56,201 0
Wand/CMS Investments I L.P. 56,556 0
Wand/CMS Investments II L.P. 19,340 0
Wand/CMS Investments III L.P. 33,595 0
Wand/CMS Investments IV L.P. 62,883 0
Paulette Beacoat 0 37
Morgan Beard 0 884
Tom Benedict 46 0
Bertrand Billiot 164 0
Eric Black 0 725
Todd Board 790 790
Rich Bogart 0 461
Ret Boney 703 0
Joe Branch 164 0
Clifton J. Brayshaw 181 181
Joseph Brehm 0 876
Matthew Bronfman 0 4,526
Thomas V. Butta 6,550 0
Christopher Cahill 0 410
James Cain IV 0 6,801
Bern Campbell 0 37
Marti Campbell 46 0
Shawn Cheston 94 0
Robert Chipman 0 74
Harold Connor 0 94
Thomas A. Cook 697 174
Mike Coppotelli 0 13,077
Thomas Cope 0 566
Steve Cureton 74 0
Andrew Curtis 0 231
Gayle Davey 0 168
Cheri DeRosia 0 119
Dave Dietrich 37 0
Dave Dixon 0 262
Paula Easton 0 12,635
Donald Ewing 0 121,910
Rick Ezell 0 703
Beryle P. Faier 1,814 0
Susan D. Faulk 7,256 7,256
Gene Feruzza 0 29,774
Joseph Ficarra III 871 217
Rick Field 0 342
Kim Frankel 0 707
Wilfer Garcia 232 57
M. Peggy R. Garner 144 0
Eric Garrett 0 1,267
Wayne Gibbons 164 0
Debbie Green 0 953
Mark Greene 0 2,281
Claude Grizzard Sr. 0 289,598
Roger L. Hackman 80,586 80,585
Michael Hail 0 121,910
Deborah Hays 0 725
Joanne Hedegard 0 411
Doug Holladay 0 2,828
Billy R. Howard 907 907
E. Dean Jones 1,814 0
Mike Keheler 263 0
Carol King 37 0
David King 0 2,789
Tracy King 37 0
Amber Kirby 0 379
Jason Kodish 0 231
Melissa E. Legge 1,450 0
Lerner Family Irrevocable Trust 21,834 21,834
Steve Lerner 29,572 29572
Thomas Liles 0 136,342
Susan Mancuso 0 1,480
Julie Mathison 39 0
Michael McCoy 0 14,512
Jennifer McMillen 0 8
Guadalupe Mendoza 1,450 0
Breck Middleton 0 417
Neesha Mirchandani 47 47
Lynne F. Moneypenny 1,814 0
Geoffrey Monsees 87 0
Crystal Montgomery 0 379
William H. Moore 907 907
Richard Muller 0 4,836
Michael E. Patterson 1,361 453
Henry B. Ponder 90,499 90,499
Jim Protzman 51,546 2,712
Archie Purcell 84,825 0
Dana Raburn 164 0
John Roberson 0 14,512
Rob Sandefuer 65 0
Charles Sanders 64 0
Colleen Sharp 0 188
Robert Sher 5,788 0
Tammie Shotwell 0 46
Robert Singer 0 263
Christine Smiley 0 297
William Taylor 0 1,881
William A. Thornton 144 0
Timothy Toben 0 125,695
Scott Tomlinson 0 725
Deborah Vrana 0 362
Carter Wagner 870 580
Curtis Walston 0 383
Jerry Wasicek 0 14,512
Scott Watkins 124 0
Stuart Webber 0 1,450
Daniel Wells 0 1,814
Jim Wheaton 0 5,474
David Wilson 0 34,822
Craig Wood 0 5,193
Christian Wright 75 0
Michelle Wright 65 0
Conroy Zien 37 0
Andrew Ziegler 0 14,512
Gary J. Zupke 1,180 634
TOTAL 641,472 1,236,299
</TABLE>
<PAGE>
Schedule 3
Y&R Selling Stockholders Who Have Granted
an Over-allotment Option to the U.S. Underwriters
<TABLE>
<CAPTION>
Number of
Shares of Common Stock Subject to the
Over-allotment Option Granted to the U.S.
Name of Y&R Selling Stockholder Underwriters
------------------------------- ------------
<S> <C>
Barbara Jack 279,292
Mitchell Kurz 71,577
Helmut Matthies 192,497
John P. McGarry, Jr. 190,294
Tim Pollak 111,000
Michael Samet 105,000
TOTAL 949,660
</TABLE>
<PAGE>
EXHIBIT INDEX
Exhibit 1 Joint Filing Agreement (incorporated by reference to the Schedule 13D
filed with the Securities and Exchange Commission on May 7, 1999)
|
|